A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research. The REIMAGINE study, published today in ...
Recent trends in the management of localized prostate cancer: Results from the National Cancer Data Base. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D. Vitamin D supplements demonstrated significant benefits in ...
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...
A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...
Poor body composition was associated with increased risk of death in men with localized prostate cancer, according to recent study findings. Body composition may play a role in the survival outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback